Truvian Sciences ("Truvian") today announced the close of a $27.1 million Series B financing — led by GreatPoint Ventures and including DNS Capital and Tao Capital Partners along with existing investor Domain Associates — to support the acceleration of the company which is developing a U.S. Food and Drug Administration (FDA)-cleared automated benchtop system to provide lab … [Read more...] about Truvian Sciences announced a $27.1 million Series B financing to Make Routine Health Testing Convenient, Affordable and Actionable